SightfileU.S. market data from official filings

SOTERA HEALTH CO (SHC)

Name: SOTERA HEALTH CO (SHC) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001822479 · EDGAR filings · Updated 2026-05-29

SOTERA HEALTH CO (SHC) has reported institutional ownership of 96.6%, with 294 institutional managers holding positions valued at $3.93B per the latest 13F reporting period.

Institutional ownership

96.6%

Institutional managers

294

Reported 13F value

$3.93B

Insider activity

46 trans.

−$2.28B net selling

Latest updates

2026-05-29 — SD filed
2026-05-27 — Insider transaction reported (Form 4)
2026-05-27 — Insider transaction reported (Form 4)
2026-05-27 — Initial insider ownership filed (Form 3)
2026-05-27 — Insider transaction reported (Form 4)
2026-05-27 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SOTERA HEALTH CO has 294 institutional holders and institutional ownership of 96.6%.

Insider activity

Insiders reported 46 transactions (0 buys, 16 sells) across 23 reporting insiders, with a net reported value of −$2.28B.

Related companies

SPYRE THERAPEUTICS INC (SYRE) · LIGAND PHARMACEUTICALS INC (LGND) · Newamsterdam Pharma Co NV (NAMS) · INDIVIOR PHARMACEUTICALS INC (INDV) · TANGO THERAPEUTICS INC (TNGX) · LIVANOVA PLC SHS (LIVN)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-05-29.